Outcome of patients with small-vessel vasculitis admitted to a medical ICU

Chest

Volumn 131, Issue 4, 2007, Pages 972-976

  Khan, S Anjum ^a   Subla, Mir Rauf ^a   Behl, Deepti ^a   Specks, Ulrich ^a   Afessa, Bekele ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Acute physiology and chronic health evaluation; Critical care; Mortality; Vasculitis; Wegener granulomatosis

Indexed keywords

APACHE; ARTIFICIAL VENTILATION; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; LUNG HEMORRHAGE; MICROSCOPIC POLYANGIITIS; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; SEPSIS; SMALL VESSEL VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 34247222763     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2464     Document Type: Article

References (25)

1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-192
2. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829
3. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
4. Lemeshow S, Teres D, Klar J, et al. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993; 270:2478-2486
5. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
6. Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 2002; 18:729-748
7. Cruz BA, Ramanoelina J, Mahr A, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford) 2003; 42:1183-1188
8. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87:671-678.
9. Zimmerman JE. Evaluation of acute physiology and chronic health evaluation III predictions of hospital mortality in an independent database. Crit Care Med 1998; 26:1317-1326
10. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-1107
11. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33:1094-1100
12. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
13. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101:1481-1483
14. Stone JH, Hoffman GS, Merkel PA, et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham vasculitis activity score; International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 2001; 44:912-920
15. Afessa B, Tefferi A, Litzow MR, et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166:641-645
16. Semple D, Keogh J, Forni L, et al. Clinical review: vasculitis on the intensive care unit; part 2: treatment and prognosis. Crit Care 2005; 9:193-197
17. Godeau B, Mortier E, Roy PM, et al. Short and long-term outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997; 24:1317-1323
18. Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992; 19:1260-1262
19. Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002; 39:42-47
20. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43:1021-1032
21. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349:36-44
22. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41:776-784
23. Tran DD, Groeneveld AB, van der Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990; 18:474-479
24. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652
25. Merkel PA, Cuthbertson D, Hellmich B, et al. Comparison of disease activity measures for ANCA-associated vasculitis [abstract]. Arthritis Rheum 2004; 50:S229